GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » 3-Year EPS without NRI Growth Rate

Tatva Chintan Pharma Chem (BOM:543321) 3-Year EPS without NRI Growth Rate : -17.50% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem 3-Year EPS without NRI Growth Rate?

Tatva Chintan Pharma Chem's EPS without NRI for the three months ended in Mar. 2024 was ₹4.13.

During the past 12 months, Tatva Chintan Pharma Chem's average EPS without NRI Growth Rate was -38.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was -17.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 6 years, the highest 3-Year average EPS without NRI Growth Rate of Tatva Chintan Pharma Chem was 65.00% per year. The lowest was -17.50% per year. And the median was 4.70% per year.


Competitive Comparison of Tatva Chintan Pharma Chem's 3-Year EPS without NRI Growth Rate

For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tatva Chintan Pharma Chem's 3-Year EPS without NRI Growth Rate Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Tatva Chintan Pharma Chem's 3-Year EPS without NRI Growth Rate falls into.



Tatva Chintan Pharma Chem 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Tatva Chintan Pharma Chem  (BOM:543321) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Tatva Chintan Pharma Chem 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Tatva Chintan Pharma Chem (BOM:543321) Business Description

Traded in Other Exchanges
Address
Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem (BOM:543321) Headlines

No Headlines